UnknownNot Applicable

Fetal, Obstetrics and Reproduction Genomics

400 participantsStarted 2023-10-01

Plain-language summary

The purpose of this study is to determine the impact of a clinical screening strategy and genomic analysis of the factors involved in Placental Dysfunction (Preeclampsia and IUGR) in women of advanced maternal age undergoing assisted reproduction techniques (ART), specifically, in vitro fertilization (IVF) and oocyte donation.

Who can participate

Age range40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Singleton pregnancy * Age ≥40 years * Signed informed consent * Gestation obtained by IVF or ovodonation Exclusion Criteria: * Non-ongoing pregnancy * Gestation obtained by artificial insemination * Naturally obtained gestation, without ART * Multiple pregnancy * Pregnancies complicated by major fetal abnormality identified at the first-trimester ultrasound * Age \<18 years * Poor understanding of the Spanish or English languages * Refusal in informed consent to participate in the study * Participation in another intervention study that could modify follow-up

What they're measuring

Number of Participants with preeclampsia (PE) during pregnancy

Timeframe: ≥20 weeks to <37 weeks of gestation

Number of fetuses diagnosed with intrauterine growth restriction (IUGR) during pregnancy

Timeframe: ≥20 weeks to <37 weeks of gestation

Trial details

NCT IDNCT05720169

SponsorFundación Ginemed

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Guillermo Antiñolo Gil, PhD, MD

0034955012772 gantinolo@us.es

View on ClinicalTrials.gov More Preeclampsia trials